Decitabine
Found 6 free book(s)DACOGEN™ (DECITABINE) FOR INJECTION
www.accessdata.fda.govMGI PHARMA, Inc. Approved Labeling NDA: 21-790 Dacogen™ (decitabine) for Injection 5/2/2006 Decitabine pharmacokinetics were characterized by
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 1 NAME OF THE MEDICINAL PRODUCT Dacogen 50 mg powder for concentrate for solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial of powder for concentrate for solution for infusion contains 50 mg decitabine.
INJECTABLE MEDICATIONS FEE SCHEDULE …
ahca.myflorida.compage 5 of 5 code description max qty rate comments/notes injectable medications fee schedule oncology 01/01/2018 j9354 ado-trastuzumab emtansine 1mg 400 29.00
DR. REDDY’S LABORATORIES LTD
www.drreddys.comdr. reddy’s laboratories ltd 2015 investor day monday, 18-may-2015 hyderabad, india nyse: rdy, nse: drreddy, bom: 500124, isin: ine089a01023
INDICATIVE LIST of APIs - GLOPEC
www.glopec.com10 Waterloo Court, Thornhill, Ontario, Canada L3t 6l9 Tel: (905) 771-6695 Fax: (905) 771-6696 E-mail: Mail@glopec.com 10/2010May 2011 01 INDICATIVE LIST of APIs
臨 床 藥 Therapeutics of Clinical Drugs 物 治 療 骨髓 …
www.taiwan-pharma.org.tw第31 卷第2期 3 25 骨髓增生不良徵候群 &q £0°) k123 83 臨 床 藥 物 治 20% 療 學 隨著疾病的惡化，骨髓芽細胞之百分比會上 升。兩者最大的差別是 fab 系統界定骨髓